Table of Content

Table of Contents

1. Executive Summary

2. Global Onychomycosis Drug Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031
3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
3.2. Global Onychomycosis Drug Market Trends (2019-2024) and Forecast (2025-2031)
3.3: Global Onychomycosis Drug Market by Type
3.3.1: Oral Medicine
3.3.2: External Medicine
3.4: Global Onychomycosis Drug Market by Application
3.4.1: Hospital Pharmacies
3.4.2: Retail Pharmacies
3.4.3: Online Pharmacies

4. Market Trends and Forecast Analysis by Region from 2019 to 2031
4.1: Global Onychomycosis Drug Market by Region
4.2: North American Onychomycosis Drug Market
4.2.1: North American Market by Type: Oral Medicine and External Medicine
4.2.2: North American Market by Application: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies
4.3: European Onychomycosis Drug Market
4.3.1: European Market by Type: Oral Medicine and External Medicine
4.3.2: European Market by Application: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies
4.4: APAC Onychomycosis Drug Market
4.4.1: APAC Market by Type: Oral Medicine and External Medicine
4.4.2: APAC Market by Application: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies
4.5: ROW Onychomycosis Drug Market
4.5.1: ROW Market by Type: Oral Medicine and External Medicine
4.5.2: ROW Market by Application: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies

5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis

6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Onychomycosis Drug Market by Type
6.1.2: Growth Opportunities for the Global Onychomycosis Drug Market by Application
6.1.3: Growth Opportunities for the Global Onychomycosis Drug Market by Region
6.2: Emerging Trends in the Global Onychomycosis Drug Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Onychomycosis Drug Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Onychomycosis Drug Market
6.3.4: Certification and Licensing

7. Company Profiles of Leading Players
7.1: Johnson & Johnson
7.2: GSK
7.3: Novartis
7.4: Pfizer
7.5: Bausch Health
7.6: Kaken Pharmaceutical
7.7: Galderma Bayer
7.8: Lumenis
7.9: Moberg Pharma
7.10: Cipla